Avicenna Introduces Machine Learning-Enhanced Medicinal Chemistry Platform to Accelerate the Last Mile of Small Molecule Drug Discovery
Business Wire
DURHAM, N.C.--(BUSINESS WIRE)--Avicenna Biosciences today introduced an extension to its machine learning (ML) technology platform..